[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Aswan University Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":96},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,71],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100557377","femoral-nerve-block-periarticular-nerve-group-peng-block-and-preoperative-iv-fentanyl-100557377",false,"NCT06537323","Femoral Nerve Block, Periarticular Nerve Group (PENG) Block, and Preoperative IV Fentanyl","Comparative Analysis of Educational Interventions and Anesthetic Techniques for Enhanced Spinal Anesthesia Quality in Fractured Neck of Femur: Femoral Nerve Block, Periarticular Nerve Group (PENG) Block, and Preoperative IV Fentanyl","Inclusion Criteria:\n\n* The included patient should be between 55 to 69 years\n\nExclusion Criteria:\n\n* known allergies to local anesthetics",true,"ALL","55 Years","69 Years",{"count":21,"type":22},210,"ESTIMATED","INTERVENTIONAL",[25],"NA","The pericapsular nerve group block is a regional anesthetic technique described in 2018, developed primarily in total hip arthroplasties for postoperative analgesia with motor sparing benefits. The block is thought to provide more complete analgesia to the hip by depositing local anesthetic within the myofascial plane of the psoas muscle and superior pubic ramus. The indications for total hip arthroplasties often include degenerative hip disease and traumatic hip fractures. These indications for surgery are relatively common in the elderly population and are associated with significant morbidity and mortality.",[28],"Postoperative Pain","RECRUITING","2025-03-11",{"date":32,"type":33},"2025-03-13","ACTUAL",{"date":35,"type":33},"2024-06-01",{"date":37,"type":22},"2025-03-10",{"name":39,"class":40},"Aswan University Hospital","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":16,"sex":17,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":23,"phases":54,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":4},"100576618","phase-1-effects-of-neostigmine-dose-on-diaphragmatic-dynamics-100576618","NCT06787638","Effects of Neostigmine-dose on Diaphragmatic Dynamics","Diaphragmatic Dynamics in Laparoscopic Cholecystectomy: Comparing Neuromuscular Blocker Reversal Strategies-A Randomized Trial","DTF\u002FDE\u002FAChE","Inclusion Criteria:\n\n* Adults scheduled for elective laparoscopic cholecystectomy.\n* Age: \\\u003C or = 18 years.\n* Both genders.\n* American Society Of Anesthiologists (ASA) I\u002FII patients.\n* BMI \\\u003C35\n\nExclusion Criteria:\n\n* Pre-existing diaphragmatic or respiratory disorders.\n* ASA III\u002FIV\n* BMI \\>35\n* Chronic opioid use or abuse\n* Pregnancy or breastfeeding","18 Years","75 Years",{"count":53,"type":22},50,[55],"PHASE1","The goal of this Randomized Clinical Trial is to compare the postoperative diaphragmatic excursion between patients receiving half-dose neostigmine (0.04 mg\u002Fkg) and those receiving full-dose neostigmine (0.08 mg\u002Fkg) for neuromuscular blockade reversal.\n\nThe main questions it aims to answer are:\n\n* Does half-dose neostigmine result in similar postoperative diaphragmatic excursion compared to full-dose neostigmine?\n* Does half-dose neostigmine result in similar diaphragmatic thickening fraction compared to full-dose neostigmine? Researchers will compare patients receiving half-dose neostigmine to those receiving full-dose neostigmine to see if there are differences in postoperative diaphragmatic function, respiratory complications, and recovery.\n\nParticipants will:\n\n* Undergo elective laparoscopic cholecystectomy.\n* Receive either half-dose or full-dose neostigmine for neuromuscular blockade reversal.",[58],"Diaphragm Ultrasound",[60,61],"Diaphragmatic Thickening Fraction","Diaphragmatic Excursion","NOT_YET_RECRUITING","2025-01-16",{"date":65,"type":33},"2025-01-22",{"date":67,"type":22},"2025-01-25",{"date":69,"type":22},"2026-04",{"name":39,"class":40},{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":4,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":78,"minAge":79,"maxAge":4,"enrollmentInfo":80,"targetDuration":4,"studyType":23,"phases":82,"briefSummary":85,"conditions":86,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":41},"100560933","phase-2-evaluation-of-efficacy-of-botulinum-toxin-a-plus-oral-tadalafil-5-mg-in-diabetic-men-with-erectile-dysfunction-100560933","NCT06583590","Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction","Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction Not Responding to Approved Oral or Intracorporeal Vasoactive Treatments.","Inclusion Criteria:\n\n* Adult controlled diabetic married men who proved to be vasculogenic ED by Penile Duplex.\n* Men who had shown an insufficient response for at least 3 months to the registered PDE5-Is at the highest approved dose, either on-demand or daily, or to PGE1 ICIs.\n* Severe erectile dysfunction (erection hardness score ≤ E3 after intracavernosal injection of PGE-1).\n\nExclusion Criteria:\n\n* Men who had cardiovascular disease interfering with sexual activity.\n* Men with history of an unstable psychiatric conditions\n* Presence of penile anatomical abnormalities that would significantly impair erectile function.\n* History of spinal or pelvic radical surgery.","MALE","21 Years",{"count":81,"type":22},32,[83,84],"PHASE2","PHASE3","Study is aiming to evaluate safety, efficacy and durability of intracavernosal injection (ICI) of Botulinum toxin A plus oral tadalafil in controlled diabetic men with refractory Erectile Dysfunction.",[87],"Erectile Dysfunction With Diabetes Mellitus","2024-11-30",{"date":90,"type":33},"2024-12-03",{"date":92,"type":33},"2024-08-01",{"date":94,"type":22},"2025-12-01",{"name":39,"class":40},""]